These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7254694)

  • 1. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis.
    Cattran DC; Steiner G; Fenton SS; Wilson DR
    Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dyslipidemia and accelerated atherosclerosis in chronic uremia: a probably decreasing pathology, due to nutritional studies and better dietary guidelines].
    Campanacci L; Guabnieri GF; Toigo G; Huber W; Legnani F; Moracchiello M; Tesio F; Raimondi A
    G Clin Med; 1978; 59(7-8):318-31. PubMed ID: 216602
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of biofiltration in uremic children.
    De Palo T; Sorino P; Bellantuono R; Colella V; Caringella DA
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():89-91. PubMed ID: 3557683
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertriglyceridemia. A metabolic consequence of chronic renal failure.
    Bagdade JD; Porte D; Bierman EL
    N Engl J Med; 1968 Jul; 279(4):181-5. PubMed ID: 5658679
    [No Abstract]   [Full Text] [Related]  

  • 7. Disorders of carbohydrate and lipid metabolism in uremia.
    Bagdade
    Nephron; 1975; 14(2):153-62. PubMed ID: 1093054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of lipid disorders in chronic hemodialyzed patients.
    Król E; Rutkowski B; Wróblewska M; Badzio T
    Miner Electrolyte Metab; 1996; 22(1-3):13-5. PubMed ID: 8676804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The abnormalities of carbohydrate and lipid metabolism in uremia. A study in 20 hemodialyzed patients (author's transl)].
    Prinseau J; Meyrier A; Domart M; Brault D; Ragot J; Etienne J
    Pathol Biol (Paris); 1980 Feb; 28(2):101-6. PubMed ID: 7005829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The abnormalities of carbohydrate and lipid metabolism in uremia. A study in 20 hemodialyzed patients (author's transl)].
    Prinseau J; Meyrier A; Domart M; Brault D; Ragot J; Etienne J
    Sem Hop; 1980 Oct; 56(37-38):1491-6. PubMed ID: 6254168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of clofibrate in uremic patients treated with dialysis. Effects of dietetic and drug therapy on triglycerides in the blood].
    Garini G; Vaona GL; Arisi L; Bignardi L; David S; Gaudiano V; Rossi E; Savazzi GM; Cambi V; Migone L
    Minerva Nefrol; 1979; 26(1):55-60. PubMed ID: 471323
    [No Abstract]   [Full Text] [Related]  

  • 12. Atherosclerosis in patients undergoing maintenance hemodialysis.
    Bagdade JD
    Kidney Int Suppl; 1975 Feb; (3):370-2. PubMed ID: 169427
    [No Abstract]   [Full Text] [Related]  

  • 13. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

  • 14. Uremic lipemia: an unrecognized abnormality in triglyceride synthesis and removal.
    Bagdade JD; Porte D; Curtis FK; Bierman EL
    Trans Assoc Am Physicians; 1968; 81():190-202. PubMed ID: 5721400
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrafiltration-pump assisted continuous arteriovenous hemofiltration (CAVH).
    Chanard J; Milcent T; Toupance O; Melin JP; Roujouleh H; Lavaud S
    Kidney Int Suppl; 1988 Mar; 24():S157-8. PubMed ID: 3129612
    [No Abstract]   [Full Text] [Related]  

  • 17. Parathyroid hormone and hyperlipemia of uremia.
    Drüeke T; Lacour B
    Contrib Nephrol; 1985; 49():12-9. PubMed ID: 3830562
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal study on hyperlipidaemia and diet in RDT patients.
    Palmo A; Boggio-Bertinet D; Balzola F; Stratta P; Triolo G; Alloatti S; Bosticardo G; Giacchino F; Pagano GF; Levis F
    Minerva Nefrol; 1982; 29(1):29-35. PubMed ID: 7048140
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertriglyceridemia in patients on hemodialysis. Changes with various therapeutic regimens].
    Barril G; Pérez García R; Vascónez F; Anaya F; Olivas E; Valderrábano F
    Rev Clin Esp; 1983 Dec; 171(5):341-5. PubMed ID: 6669764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary trials of dialysis with a bath fluid of low acetate content. Relation to triglycerides].
    Bandiani G; Camaiora E; Nicolini MA; Perotta U
    Minerva Nefrol; 1979; 26(1):75-7. PubMed ID: 471327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.